Yes agree
A breakdown on Spenda client numbers, new integration numbers, ARPU, bnpl uptake, approx transaction numbers total, this would give the market clarity on current metrics as a base to work from
For a monthly example
Spenda current clients 500
New integrations this month 20
ARPU $250
Revenue $750,000 month
Transactions mth $50,000,000
Gross revenue (before splits) $750,000
Net rev (CRO split) $130,000
Invigo
current revenue month $70k
current clients 15
new clients 5
ARPU $3500 mth
Something like this that can be tracked for progress would be welcome and give the market a better understanding overall imo
Hiding behind well we did 100% more in cash receipt than in Q1 2020 is irrelevant, as holders say CRO is not what it was 12 months ago yet the CEO uses it to justify a horrible 4C
The marketing spend from memory was $70k or something ridiculous which shows driving revenue is surely not their immediate goal, if that is the case, explain the runway better and not with we will be cashflow positive or neutral shortly
They do the above they'll get my respect with transparent numbers
PS: This market tech funding line was it ever announced to the market?
- Forums
- ASX - By Stock
- SPX
- it's just the beginning for Cirralto!
SPX
spenda limited
Add to My Watchlist
9.09%
!
0.6¢

it's just the beginning for Cirralto!, page-16820
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
0.6¢ |
Change
0.001(9.09%) |
Mkt cap ! $27.69M |
Open | High | Low | Value | Volume |
0.6¢ | 0.7¢ | 0.6¢ | $23.32K | 3.880M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 280696 | 0.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.7¢ | 18216262 | 29 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 280696 | 0.006 |
48 | 22729523 | 0.005 |
8 | 15700000 | 0.004 |
9 | 26100000 | 0.003 |
5 | 17000002 | 0.002 |
Price($) | Vol. | No. |
---|---|---|
0.007 | 17544441 | 26 |
0.008 | 3921694 | 23 |
0.009 | 9234397 | 15 |
0.010 | 842781 | 5 |
0.011 | 527004 | 4 |
Last trade - 15.59pm 27/06/2025 (20 minute delay) ? |
Featured News
SPX (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online